Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
NHS eligibility criteria under NICE TA875 are more restrictive than the MHRA licence, with specific BMI thresholds and service requirements
Frequency varies, but many clients receive treatments weekly or bi-weekly , then transition to monthly maintenance
This variability means compounded tirzepatide may not produce the same results documented in Zepbound's trials, so you cannot use Zepbound's clinical evidence to predict outcomes with a compounded formulation
Some patients remain at lower doses longer if results are already strong
However, the overall risk appears to be small, researchers noted
US$ 20.82
US$ 23.14
:max_bytes(150000):strip_icc()/VWH-GettyImages-2196287905-42e440cc5f714dfb8793161a905904d9.jpg)
US$ 21.64
US$ 28.63
:max_bytes(150000):strip_icc()/Health-GettyImages-2200929852-cbe13f76512c4cd3b51252536927920f.jpg)
US$ 20.10
US$ 28.05
